[HTML][HTML] Pneumococcal vaccination in adults: what can we learn from observational studies that evaluated PCV13 and PPV23 effectiveness in the same population?

EM Dunne, C Cilloniz, C von Mollendorf… - Archivos de …, 2023 - Elsevier
Introduction Fifteen and 20-valent pneumococcal conjugate vaccines (PCV15; PCV20) were
recently licensed to prevent pneumococcal disease in adults. In the absence of efficacy or …

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States

AD Wiese, MR Griffin, CG Grijalva - Expert review of vaccines, 2019 - Taylor & Francis
Introduction: Pneumonia is one of the leading causes of morbidity and mortality among
children and older adults. Pneumococcal conjugate vaccines (PCVs) were introduced into …

Pneumococcal vaccination in older adults: an initial analysis of social determinants of health and vaccine uptake

J Gatwood, S Shuvo, KC Hohmeier, T Hagemann… - Vaccine, 2020 - Elsevier
Objectives To examine the potential influence of social determinants of health on
pneumococcal vaccination in older American adults. Methods This study used nationwide …

[HTML][HTML] Health care provider knowledge and attitudes regarding adult pneumococcal conjugate vaccine recommendations—United States, September 28–October 10 …

R Kahn - MMWR. Morbidity and mortality weekly report, 2023 - cdc.gov
Despite the availability of effective vaccines against pneumococcal disease, pneumococcus
is a common bacterial cause of pneumonia, causing approximately 100,000 hospitalizations …

Understanding predictors of pneumococcal vaccine uptake in older adults aged 65 years and older in high-income countries across the globe: A scoping review

S Nasreen, GB Gebretekle, M Lynch, A Kurdina… - Vaccine, 2022 - Elsevier
Background Pneumococcal disease causes substantial morbidity and mortality in older
adults. Pneumococcal polysaccharide vaccine (PPV23) is routinely recommended to reduce …

Challenges facing vaccinators in the 21st century: results from a focus group qualitative study

F Wiot, J Shirley, A Prugnola… - Human vaccines & …, 2019 - Taylor & Francis
Introduction: Barriers to vaccination and the important role of healthcare professionals
(HCPs) in influencing immunization decisions made by parents/patients have been well …

[HTML][HTML] General practitioners' awareness and perception of current pneumococcal vaccination for adult patients with known risk factors in Switzerland: evidence from …

ST Stoffel, M Schwenkglenks, T Mutschler - Vaccines, 2023 - mdpi.com
In Switzerland, the National Immunization Advisory Group (NITAG) has formulated
recommendations for pneumococcal vaccination among adult risk patients. Little is known …

Previsit planning improves pneumococcal vaccination rates in childhood-onset SLE

V Sivaraman, KA Wise, W Cotton, F Barbar-Smiley… - …, 2020 - publications.aap.org
BACKGROUND: Childhood-onset systemic lupus erythematosus (c-SLE) is a complex
autoimmune disease that requires systemic immunosuppressive therapy. Infections are the …

[HTML][HTML] Health care professionals' herpes zoster awareness and vaccine recommendations for patients with COPD

BP Yawn, NY Loskutova, DD Merrill… - … Diseases: Journal of …, 2022 - ncbi.nlm.nih.gov
Objectives: The objective of this study was to assess health care professionals'(HCPs)
knowledge of an increased herpes zoster (HZ) risk and burden for patients with chronic …

Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the Juvenile …

V Rollet-Cohen, J Mirete, G Dingulu, F Hofer… - Clinical …, 2021 - Springer
Introduction/objectives To determine vaccination coverage among a French cohort of
children with recurrent autoinflammatory fever syndromes (RFS). Method All RFS children …